Abstract: Disclosed are methods and kits for screening potential inhibitors of MutS? by screening agents for the ability to selectively inhibit interaction between MutS? and MutL?. Also disclosed are kits for performing the methods of the invention.
Type:
Grant
Filed:
February 11, 2011
Date of Patent:
January 7, 2014
Assignees:
Duke University, The United States of America, as Represented by the Secretary of Energy
Inventors:
Paul L. Modrich, Ravi R. Iyer, Anna Pluciennik, Miaw-Sheue Tsai
Abstract: A method and apparatus is disclosed for casting conductive and semiconduce materials. The apparatus includes a plurality of conductive members arranged to define a container-like area having a desired cross-sectional shape. A portion or all of the conductive or semiconductive material which is to be cast is introduced into the container-like area. A means is provided for inducing the flow of an electrical current in each of the conductive members, which currents act collectively to induce a current flow in the material. The induced current flow through the conductive members is in a direction substantially opposite to the induced current flow in the material so that the material is repelled from the conductive members during the casting process.
Type:
Grant
Filed:
August 13, 1984
Date of Patent:
February 25, 1986
Assignee:
The United States of America as represented by the Secretary of Energy
Abstract: A method for synthesizing alpha amino acids proceding through novel intermediates of the formulas:R.sub.1 R.sub.2 C(OSOCl)CN, R.sub.1 R.sub.2 C(Cl)CN and [R.sub.1 R.sub.2 C(CN)O].sub.2 SOwherein R.sub.1 and R.sub.2 are each selected from hydrogen monovalent substituted and unsubstituted hydrocarbon radicals of 1 to 10 carbon atoms. The use of these intermediates allows the synthesis steps to be exothermic and results in an overall synthesis method which is faster than the snythesis methods of the prior art.
Type:
Grant
Filed:
June 29, 1981
Date of Patent:
January 25, 1983
Assignee:
The United States of America as represented by the Secretary of Energy
Abstract: Palladium-109, a beta-emitting radionuclide, when chelated to anti-melanoma monoclonal antibody demonstrates high uptake in melanoma and thus is useful for tumor therapy.
Type:
Grant
Filed:
April 30, 1984
Date of Patent:
September 4, 1990
Assignee:
The United States of America as represented by the Secretary of Energy
Inventors:
Suresh C. Srivastava, Rashid A. Fawwaz, Soldano Ferrone